Longevity Pulse Daily Digest
Longevity Pulse Daily Digest
Longevity Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
No curated digest available for this date. Showing live feed content.
Wednesday, April 8, 2026
Market Intelligence for Longevity Professionals
University of Arizona launches $12M rapamycin trial for seniors
The R. Ken Coit College of Pharmacy is starting a double‑blind, randomized Phase 3 study to test low‑dose rapamycin’s ability to improve resilience and immune function in adults aged 65 and older. The six‑year trial, funded by a $12 million philanthropic gift from alumnus Ken Coit, will randomize participants to rapamycin or placebo for two years before long‑term follow‑up.
There are no major news stories for Longevity today. Check back later for updates.
Source: Pulse AI
